SCHEMBL23082052

SCHEMBL23082052

CC(c1ccc(C2CCCCC2)cc1)(c1c(O)ccc2cc(O)ccc12)c1c(O)ccc2cc(O)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 2/20 0.37
▸ DEGS1 O15121 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2D6 P10635 3/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ESR2 Q92731 9/20 0.35
▸ HSP90AB1 P08238 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861591 0.91 CYP2D6 (0.38) ACMSDDEGS1CYP3A4CYP2C9CYP2D6
SCHEMBL23861474 0.85 ALDH1A1 (0.46) ACMSDCYP3A4CYP2C9CYP2D6CYP1A2
SCHEMBL23861565 0.84 ESR1 (0.40) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL23861415 0.80 ESR1 (0.47) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL23082096 0.79 DEGS1 (0.35) DEGS1CYP3A4CYP2C9CYP2D6ESR2
SCHEMBL23861442 0.77 ESR2 (0.49) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL23082023 0.77 DEGS1 (0.53) DEGS1CYP3A4CYP2C9CYP2D6ESR2
SCHEMBL23861643 0.77 MAPT (0.38) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL23082053 0.76 ESR1 (0.54) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL23861567 0.74 ESR1 (0.41) CYP3A4CYP2C9ALDH1A1HSD17B10ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed
US-20210070683-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed
US-20210070727-A1 COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed
US-20210070685-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070683-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD RER1, RTN4, FEM1B ACMSD 1347/4885DEGS1 1819/4885CYP3A4 2950/4885
US-20210070727-A1 COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD RDX, RTN4, CROCC ACMSD 607/4885DEGS1 1438/4885CYP3A4 1399/4885
US-20210070685-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD RER1, RTN4, FEM1B ACMSD 1347/4885DEGS1 1819/4885CYP3A4 2950/4885
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ACMSD 1310/4885DEGS1 1464/4885CYP3A4 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback